CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 190 enrolled
Drug / intervention
DHA +1 moredrug
Likely dose
DHA 600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02487771
NCT02487771Phase 3Completed
CompareCT.gov

Kansas University DHA Outcome Study (KUDOS) Follow-Up

Susan Carlson, PhD·interventional·Posted Jul 1, 2015·Updated Feb 7, 2018

In Brief

A Phase 3 clinical trial evaluating DHA and Placebo Capsule for Pregnancy. Completed, enrolled 190 participants across 1 site.

Detailed Summary

This is a continuation study to KUDOS (NCT00266825). The purpose of this study is to follow-up with participants on the original study to determine if the effects of increasing DHA intake during pregnancy increase cognitive development in 2 to 6 year-old children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 1, 2015
Enrollment StartJul 1, 2008
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 11.0 years ago

Interventions

DHAdrug

600 mg DHA capsule

Placebo Capsuledrug

600 mg of Soybean Oil and Corn Oil, which does not contain any DHA